Bausch Health Companies Inc. (BHC) SEC Filing 8-K Material Event for the period ending Friday, March 8, 2019

Bausch Health Companies Inc.

CIK: 885590 Ticker: BHC

View differences made from one to another to evaluate Bausch Health Companies Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bausch Health Companies Inc..


Assess how Bausch Health Companies Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bausch Health Companies Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Bausch Health Companies Inc. provided additional information to their SEC Filing as exhibits

Ticker: BHC
CIK: 885590
Form Type: 8-K Corporate News
Accession Number: 0001193125-19-069218
Submitted to the SEC: Fri Mar 08 2019 4:45:34 PM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Friday, March 8, 2019
Industry: Pharmaceutical Preparations
  1. Financial Exhibit
  2. Financial Obligation Increase
  3. New Agreement
  4. New Financial Obligation
  5. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: